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A B S T R A C T
A novel thermophilic bacterial strain of the genus Aeribacillus was isolated from Thar Dessert Pakistan.
This strain showed signiﬁcant antibacterial activity against Micrococcus luteus, Staphylococcus aureus, and
Pseudomonas aeruginosa. The strain coded as ‘SAT4’ resembled with Aeribacillus pallidus in the
morphological, biochemical and molecular tests. The production of antibacterial metabolites by SAT4
was optimized. These active metabolites were precipitated by 50% ammonium sulphate and puriﬁed
through sephadex G-75 gel permeation chromatography and reverse phase HPLC. The molecular weight
of 37 kDa was examined by SDS-PAGE. The structural elucidation of the puriﬁed product was studied by
FTIR, 1H and 13C NMR. The X-ray diffractions study showed that the crystals belonged to the primitive
orthorhombic lattice (a = 12.137, b = 13.421, c = 14.097 Å) and 3D structure (proposed name: Aeritracin)
was determined. This new peptide antibacterial molecule can get a position in pharmaceutical and
biotechnological industrial research.
ã 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Microorganisms make up an everlasting reservoir of chemical
compounds with pharmacological, physiological, medical or
agricultural uses [45] and many bio active small molecules are
synthesized by these naturally populated microbes [21,10]. The
number of bioactive chemical compounds has been reported by
bacilli, pseudomonas, actinomycetes and fungi [27]. Among them
800 peptide antibiotics have been described [33] and of this total,
66 various peptide antibiotics are particularized by strains of
Bacillus subtilis and 23 are active metabolites of Bacillus brevis
[18,31,20]. Some of these antibiotics including the polypeptide are
being used against the common bacterial targets and thus having
the broad spectrum activity. Bacilli producing peptide antibiotics
(gramicidins, tyrocidines, and bacitracins) are mainly mesophilic
[15]. Few of them are capable of growing at temperatures above
40 C. They include B. brevis var. G-B, producing gramicidin C [14],
and Bacillus polymyxa, producing gavaserin and saltavalin [38].
Aeribacillus pallidus belongs to class Bacilli and its growth occurs at
55–60 C. Although the progress and speed of new antibiotic* Corresponding author.
E-mail addresses: aunmuhammad78@yahoo.com (S.A. Muhammad),
saﬁamrl@yahoo.com (S. Ahmed).
1 Institute of Molecular Biology and Biotechnology, Bahauddin Zakariya
University, Multan 60000, Pakistan.
http://dx.doi.org/10.1016/j.btre.2015.09.003
2215-017X/ã 2015 The Authors. Published by Elsevier B.V. This is an open access article undiscovery has indeed slowed down [51] but in recent years the
natural products are the most effective source of drugs and have
gained valuable attention for their clinical practices and consistent
therapeutic value. Therefore the importance and signiﬁcance of
antibiotics to medicine has led to much research into their
discovery and production [29]. Here we describe the production
and characterization of a new antibiotic molecule obtained from a
newly isolated thermophilic A. pallidus strain SAT4.
2. Materials and methods
2.1. Isolation and screening
Thermophilic bacterial strains were isolated from soil sample of
Thar Dessert, Pakistan by serial dilution method. Bacterial colonies
were puriﬁed on nutrient agar medium at 50 C by standard streaks
plate technique. Antibacterial activity of these puriﬁed isolates
were checked against Micrococcus luteus ATCC 10240, Staphylococ-
cus aureus ATCC 6538, Pseudomonas aeruginosa ATCC 49189 and
Escherichia coli ATCC 87064 by agar well diffusion assay.
2.2. Characterization
The puriﬁed bacterial isolate SAT4 was characterized on the
basis of morphological, biochemical and genomic analysis.der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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The morphological parameters were studied according to
Buchanan and Gibbons [8]. For evaluation of colony morphology,
under aseptic techniques, the puriﬁed and isolated colony was
grown on nutrient agar media and was studied for colony
morphology (size, pigmentation, form, margin, and elevation),
gram’s staining, spore staining and bacterial motility.
2.2.2. Biochemical study
The combination of API 50CHB V4.0 and API 20E kit (BioMerieux
SA France; Lot No. 833022401) was used for biochemical analysis
according to the manufacturer’s protocol and test results were
recorded after 24 h of incubation. The results were analyzed into a
bio- Me’rieux identiﬁcation software database (apiwebTM; Bio-
Merieux SA).
2.2.3. Molecular study
A 16S rRNA gene sequence to study bacterial phylotypes and
taxonomy was used to identify bacterial isolate. DNA was extracted
from bacterial cultures using Wizard genomic Kit (Promega,
Madison, USA) according to the manufactures’ speciﬁcations. DNA
concentration in sample was determined using Nanodrop1000
(Thermo Scientiﬁc, Rockford, USA) as per standard procedure.
PCR ampliﬁcation and sequencing of 16S rRNA gene was carried
out using a Takara 16S rDNA bacterial identiﬁcation kit. 1 ml
of the extracted DNA was ampliﬁed with universal primers
F27 (50-AGAGTTTGATCMTGGCTCAG-30) and R907 (50-
CCGTCAATTCCTTTRAGTTT-30), generating a PCR product. All
reactions were carried out in 0.5 ml PCR tubes, containing 1 ml
of each primer, 9.5 ml of sterile distilled water and 12.5 ml of Master
Mix (PCR Master Mix 2X, Fermentas, #K0171). PCR was performed
in a T-Personal combi PCR machine (Biometra, Germany,
#2106284) with the following program: 3 min denaturation at
95 C, followed by 30 cycles of 1 min denaturation at 94 C, 1 min
annealing at 58 C, 1 min extension at 72 C, and a ﬁnal extension
step of 3 min at 72 C. PCR product of the correct size was puriﬁed
by JET quick PCR products puriﬁcation spin/250 kit (GENOMED,
Germany). Extracted DNA was visualized by gel electrophoresis on
0.8 % agarose gel and 5 ml of PCR products on 1.5% agarose gel
stained with ethidium bromide (0.5 mg/ml) in 1 TAE buffer
(50 TAE buffer: 242 g/l Tris, 18.61 g/l NaEDTA.2H2O, 57 ml glacial
acetic acid). About 1 ml loading dye (30% v/v glycerol, 0.25 % w/v
bromophenol blue, 0.25 % w/v xylene cyanol FF) was added to 3 ml
of sample and mixed before loading into wells. DNA ladder (Kbp)
(Fermentas GeneRulerTM, #SM0313) was used for PCR products.
2 ml of ladder was mixed with 2 ml of loading dye before its loading
in the ﬁrst well of the gel. The gel was run at 80 V for 45 mins. The
gel was then observed for bands under UV using gel-dock imaging
system (BioRad, Milan Italy).
Sequencing of PCR products was performed and analyzed in
both directions using an ABI Prism 310 automated DNA sequencer
using BigDye Terminator cycle sequencing kit (PE Applied and
Biosystem USA). This kit contained a BigDye Terminator tube, ﬁlled
with 10 ml of pinkish solution containing 2 ml of primer and 8 ml of
BigDye Terminator Reagent. 10 ml of puriﬁed PCR product wasTable 1
Antibacterial activity of selected thermophilic bacterial isolates against indicator bacte
Indicator bacterial species Zone of inhibitions shown by the t
SAT1 SAT2 
Staphylococcus aureus ATCC 6538 2 2 
Micrococcus luteus ATCC 10240 1 2 
Pseudomonas aeruginosa ATCC 49189 0 0 
E. coli ATCC 87064 0 0 transferred to this Big Dye Terminator tube. Then samples were
sequenced. Basic Local Alignment Search Tool (BLAST) at the
National Center for Biotechnology Information (NCBI) was used to
align the obtained bacterial 16S rDNA sequence with thousands of
known different available 16S rDNA sequences in this database,
and percent homology scores were generated to identify bacteria.
Phylogenetic tree was constructed by the neighbor-joining method
[40] using the MEGA 4.0 software package. Bacteria with 16S rDNA
sequences >99% similarity was considered to be of the same
phylotype [19].
2.3. Production of antibacterial compound
Shake ﬂask fermentation experiments were carried out for the
production of antibacterial metabolites by bacterial isolate SAT4.
100 ml of production medium [9] (L-glutamic acid: 5 gm/l;
KH2PO4:0.5 gm/l; K2HPO4:0.5 gm/l; MgSO4:0.2 gm/l; MnSO4:0.01
gm/l; NaCl:0.01 gm/l; FeSO4:0.01 gm/l; CuSO4:0.01 gm/l;
CaCl2:0.015; Glucose:1%) was inoculated with 10% of bacterial
inoculum and it was incubated at 50 C in shaking incubator for
24 h at 150 rpm. After 24 h of incubation, sample was centrifuged
for 15 min at 10,000 rpm by table top centrifuge to get cell free
supernatant and antibacterial activity in the supernatant was
analyzed against test bacterial strains by agar well diffusion assay
[24,42].
2.4. Optimization of the production of antibacterial compound
The production of antibacterial compound was optimized by
analyzing the time of incubation, pH, temperature, agitation rate,
nitrogen, and carbon concentrations. Incubation time was
analyzed from 24 to 144 h; pH was studied from 4 (acidic) to 9
(basic); temperature ranged from 45 to 60 C; the concentration of
glutamic acid used as a source of nitrogen varied from 0.25 to 2%;
and carbon concentration by taking the glucose from 0.25 to 3%.
The optimum levels were conﬁrmed by agar well diffusion assay.
2.5. Puriﬁcation of antibacterial compound
Precipitation, a method of protein puriﬁcation [25] was carried
out by ammonium sulphate [48,11]. The culture supernatant was
treated with powdered ammonium sulphate (20, 40, 50, and 60%
saturation). After sufﬁcient shaking, solution was placed in the cold
for one hour and precipitates were collected by centrifugation at
14,000 rpm for 15 min at 4 C. The precipitates were resuspended
in 15 ml of 0.05 M potassium phosphate buffer at pH 6. Dialysis was
carried out against the same buffer for 24 h in dialyzing bag and the
pallets were freeze dried. Further puriﬁcation was processed by gel
permeation chromatography. The column was carefully loaded
with 3% sephadex G-75 gel suspended in 0.05 M phosphate buffer.
The dialyzed protein sample was eluted at a ﬂow rate of 36 ml/h
and fractions (3 ml each) were collected. The absorption of these
fractions was measured at 280 nm by UV-spectrophotometer
(Agilent USA). The fraction showing antibacterial activity were
pooled and lyophilized. The activity of these fractions were testedrial strains.
hermophilic bacterial isolates (mm)
SAT3 SAT4 SAT5
4 25 6
2 22 6
0 16 1
0 5 0
74 S.A. Muhammad, S. Ahmed / Biotechnology Reports 8 (2015) 72–80against indicator bacterial strains by agar well diffusion method.
Finally, the puriﬁed sample was analyzed by reverse phase HPLC
(C18 column; 5 mm; 4.6 mm  150 mm) using isocratic elution of
20 mM Na2HPO4/130 mM NaCl at a ﬂow rate of 1.0 ml/min.
Polymyxin B was taken as standard peptide antibiotic due to
same class of metabolite sample.
2.6. SDS-PAGE analysis
In order to monitor purity, sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis (SDS-PAGE) was performed using 12% of
resolution gel and 5% of stacking gel [30]. Sample was prepared by
dissolving it with equal proportion of sample buffer and loaded
onto several wells along with Prestained Protein Ladder (Fermen-
tas, PageRuler, #SM 0671). One-half of the gel was stained with
coomassie brilliant blue according to the method of Lee et al. [30]
while the other half was assayed directly for antibacterial activity
by the modiﬁed test [7].
2.7. FTIR and NMR analysis
FTIR spectra of sample were recorded in 3600–650 cm1 region
by Bruker Germany Alpha FT-IR model. The samples for NMR
analysis were prepared by dissolving 15 mg of sample in 0.5 ml
D2O. NMR spectra were analyzed using Bruker 300 MHz spec-
trometer equipped with 5 mm of probehead for 1H and 13C
analysis.
2.8. X-ray crystallography
Crystals of the lyophilized sample were developed at room
temperature. The method involved mixing 2 ml of solvent solution
(70% CH3OH) with lyophilized sample (10 mg/ml) in a test tube for
30 h. Diffraction data related to X-ray crystal structure were
collected, processed, and calculated from a single crystal source
using a STOE-IPDS II equipped with an Oxford Cryostream low-
temperature unit, Germany. Structure solution and reﬁnement was
done using SIR97, SHELXL97 and WinGX. During data collection,Table 2
Taxonomic characterization of bacterial isolates SAT4.
Test analysis Types 
Microscopic examination 
Morphological characteristics 
Macroscopic appearance: colony morphology 
Biochemical
characteristicsc
API 50CHB Tests that were positive fora
GLY GLU FRU MNE MAN SOR MDG NAG AMY ARB ES
+ + + + + + + + + + + + + + + +
API 20E Tests that were positive forb
ONPG CIT GEL INO RHA ARA
+ + + + + +
Signiﬁcant Taxon 98.4 % Geobacillus pallidus
Molecular Universal primers F27 and R907
Characteristics 100% homology with Aeribacillus pallidus at NCBI serv
Indications: + sign indicates the positive reaction (color change), GLY: glycerol; GLU: D-
acetylglucosamine; AMY: amygdalin; ARB: arbutin; ESC: esculin ferric citrate; SAL: sal
a Only the tests with a positive result are included here (remaining tests were negat
b Only the tests with a positive result are included here (remaining tests were negative
INO: inositol; RHA: L-rhamnose; ARA: L-arabinose.
c Biochemical tests: API kit system with percentage of positive tests after 24 h of incthe crystal was maintained at cryogenic temperatures so as to
reduce radiation damage.
2.9. Thermostability analysis
Thermostability was evaluated by taking 0.1% aqueous solution
of pure compound in four different test tubes, kept them for one
hour in water bath at 45, 50, 55, and 60 C. Agar well diffusion
method was used to measure the activity against S. aureus and M.
luteus. The antibacterial activity of untreated sample measured at
37 C was taken as control. Percentage loss of antibacterial activity
was calculated using the following formula:
A0  AfA0  100
where A0: activity of control, Af: activity after treatment.
3. Results
3.1. Screening of antibacterial producing bacterial species
Five isolates were puriﬁed (coded as SAT1 to SAT5) and
antibacterial activity of strain “SAT4” showed maximum activity
against S. aureus giving zone of inhibition of 25 mm followed by the
22 mm inhibitory zone against M. luteus (Table 1).
3.2. Characterization
Morphologically bacterial isolate SAT4 was a motile, spore
forming and Gram positive rod arranged in pairs and colonies were
white to off white in color, circular, ﬂat, with entire margins. 98.4%
signiﬁcant taxon was identiﬁed as Geobacillus pallidus strain SAT4
(now known as A. pallidus) [34] when tested through biochemical
kits (Table 2). 16S rDNA sequence was ampliﬁed using universal
primers F27 and R907 generating a PCR product. Analysis of the
16S-rRNA gene sequences using NCBI server, this thermophilic
bacterium showed 100% similarity with A. pallidus (accession
number: JN986827). The maximum-likelihood phylogenetic tree
and evolutionary relationship was analyzed (Fig. 1).Features Result
Gram’s staining +
Shape Rods arranged in pairs
Spore formation +
Motility +
Color White to off
Elevation Flat
Colony shape Circular
Margins Entire
C SAL CEL SAC TRE LFUC
er (accession number: JN986827) previously known as Geobacillus pallidus [21]
glucose; FRU: D-fructose; MNE: D-mannose; MAN: D-mannitol; SOR, MDG, NAG: N-
icin; CEL: D-cellobiose; SAC: D-sucrose; TRE: trehalose; LFUC: L-fucose.
ive).
). ONPG: 2-nitrophenyl-ß-D-galactopyranoside; CIT: trisodium citrate; GEL: gelatin;
ubation.
Fig. 1. Evolutionary and phylogenetic relationship of Aeribacillus pallidus SAT4 with 47 taxa (linearized).
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The maximum production of antibacterial metabolites was
observed at following parameters: 48 h of incubation, pH 5, 2%
glucose, 1.5% glutamic acid, 100 rpm, and 55 C temperature
(Fig. 2).
3.4. Puriﬁcation analysis
Antibacterial compound was puriﬁed using 50% saturated
ammonium sulphate followed by the fractionation through
sephadex G-75 gel permeation chromatography and protein
concentration were estimated at 280 nm (Supplementary Fig. 1).
The retention time of protein sample was 13.109 min when eluted
through HPLC at 254 nm as compared to polymyxin as standard
protein antibiotic at 11.952 min. These spectral peaks distinctively
characterize the peptide antibiotic and differentiate them from
other polypeptide antibiotics (Supplementary Fig. 2).
Supplementary material related to this article found, in the
online version, at http://dx.doi.org/10.1016/j.btre.2015.09.003.
3.5. SDS-PAGE analysis
SDS-PAGE analysis of puriﬁed sample revealed single band at
37 kDa (Fig. 3). Zone of inhibition against S. aureus was observed
when gel overlay test was performed at 37 C corresponding to the
protein band at the same position.Fig. 2. Optimization of antibacterial compound production by Aeribacillus pallidus SAT4 (
used as carbon source (d) glutamic acid concentrations, used as nitrogen source (e) Ef3.6. FTIR analysis
The spectrum of this ligand exhibited weak bands in the 3400–
3100 cm1 region; while strong bands appeared in the region of
3600–3500 cm1may be due to presence of HOH (asymmetric
vibration). Similarly a band at 2900 cm1 was observed which
belongs to (¼CH) stretching. The strong bands belong to
(C¼N), and (C¼O) were found at 2359.86 cm1. In the spectrum
of peptide ligand, other bands at 1700 cm1, 1540.81 cm1 and
1257.49 cm1 were appeared which attributed to asymmetric
interaction (ONO), (NH) and (CO), respectively. The
peptide bond formation could also be conﬁrmed due to NH
stretching and CO in frequency regions of 1540.81 and
1257.49 cm1, respectively with small contribution of CN group
(Table 3).
3.7. NMR analysis
The 1H NMR spectrum of sample showed the signals about
aliphatic groups. A CH3 resonance was observed at 1.195 ppm,
while CCH2C (sp3 hydrogen) were recorded at 1.571 ppm.
At high dilution, hydroxyl protons (OH) showed absorption near
0.5–1.0 ppm (0.751 ppm), while in concentrated solution their
absorbance was closer to 4.5 ppm and it was not observed in the
spectrum. The resonance of alkyl amines (RNH2) was observed at
3.996 ppm (Supplementary Fig. 3a). 13C NMR spectra were used to
determine the number of nonequivalent carbons and to identify
the types of carbon atoms which may be present in the compound.a) effect of Incubation time (hours) (b) various pH values (c) glucose concentrations,
fect of agitation (rpm) rates (f) Effect of different temperatures.
Fig. 3. SDS-PAGE analysis (La: Ladder; Lane 1: protein sample).
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carbon CH3, CH2 appeared at 28.190 ppm and 28.738 ppm,
respectively. The resonance at 69.69 ppm showed the effects of
electronegative atom (CO) (Supplementary Fig. 3b).
Supplementary material related to this article found, in the
online version, at http://dx.doi.org/10.1016/j.btre.2015.09.003.
3.8. Structure identiﬁcation by X-ray crystallography
Antibacterial compound (proposed name: Aeritracin) isolated
from A. pallidus SAT4 was subjected to X-ray diffraction study. The
geometry of polypeptide contains various amino acids residues
(Fig. 4a). The crystal system is triclinic with molecular formula of
C55H82N16O17 showing the presence of histidine C27-N28 withTable 3
Prominent FT-IR bands for antibacterial peptide compound.
Compound FT-IR (cm1)
Thermostable peptide antibacterial compound
produced by Aeribacillus pallidus SAT4
3600–3650 stretching (OH
1786 (R2C¼CR2), 1820–1760 
1600–1475 stretching (C¼C)
disubstituted ring), 668 benbond lengths of (1.32909 Å (1.5)), N28-C29 (1.32989 Å (1.5)), C29-
N30 (1.32887 Å (1.5)), N30-C31 (1.33197 Å (1.5)) and C31-C27
(1.38236 Å (1.5)). The selected bond lengths of (1.39026 Å (1.5)) and
(1.39138 Å (1.5)) from C38-C43 and C71-C76, respectively showed
the presence of two benzene rings. The bond lengths of (1.23148 Å
(2)), (1.34144 Å (1)) and (1.55458 Å (1)) exhibited the existence of
C¼O (C9-O1), CN (C9-N11) and CC (C12-C13), respectively. The
crystals belong to the primitive orthorhombic lattice with the cell
parameters a = 12.137, b = 13.421, c = 14.097 Å (Fig. 4b). The
analytical data (Table 4) and the selected bond lengths are given
in Supplementary Table S1.
Supplementary material related to this article found, in the
online version, at http://dx.doi.org/10.1016/j.btre.2015.09.003.
3.9. Thermostability of the antibacterial compound
Thermostability of cell free supernatant and pure compound
was tested at 45, 50, 55, and 60 C and antibacterial activity was
evaluated against S. aureus and M. luteus (indicator strains) by agar
well diffusion assay. At 55 C, 22 and 18 mm inhibitory zones were
observed against M. luteus and S. aureus, respectively while activity
was reduced at 60 C (Table 5) while pure antibacterial compound
using 0.1% concentration showed 25 and 22 mm inhibitory zones
against these indicator strains, respectively at 37 C.18 and 20% loss
of activity was observed against same strains at 45 C, respectively.
4. Discussion
A. pallidus belong to genera Bacilli [51,6] producing antibacterial
molecule against S. aureus, M. luteus, and P. aeruginosa. The
bacterial metabolites possessing antimicrobial or antifungal
activity including peptides [52] are getting worth now a day
and due to number of clinical concerns their usage is important
[41,47]. A. pallidus SAT4, a thermophilic bacterium, produced
peptide antibacterial metabolites at 50 C. In spite of the great
attention to microorganisms living under extreme environmental
conditions, including thermophiles [2] the secondary metabolism
of thermophilic microorganisms is poorly understood and virtually
nothing is known of thermophilic bacilli producing antibacterial
substances, including peptides. Mostly peptide antibiotics are
produced by mesophilic bacterial cultures [15]. Few of them are
capable of growing at temperatures above 40 C. They include B.
brevis G-B, producing gramicidin C [14], B. polymyxa in gavaserin
and saltavalin [38] and Bacillus licheniformis DSM-13 producing
peptide lantibiotics [13]. Bacitracin is a mixture of related cyclic
polypeptides with molecular formula of C66H103N17O16S produced
by mesophilic bacterial strain B. subtilis. It is broad spectrum
antibiotic that disrupt both gram positive and gram negative
bacteria by interfering with cell wall and peptidoglycan synthesis
[44]. In 2002, Esikova et al. [17] reported the thermophilic Bacillus
species strains VK2 and VK21 involved in the production of peptide
antibacterial molecules. Streptomyces species SRDP-TK-07 has
been reported to produce antibacterial metabolites at 45 C [39].
Geobacillus toebii HBB-247, a thermophilic bacteria isolated from
different thermal spring and soil has been reported for the
production of bacteriocin like inhibitory substance which was
found to be stable up to 60 C [37].), 2990–2800 stretching (CH sp3), 2359 stretching (N¼C¼O or N¼C), 1860–
(C¼O), 1540 bending (NH), 1690 (O¼CNH2), 1400–1220 week for (COH),
, 1257 stretching (CO), 1015 (R-COR2-R), 750 bending (CH2), 794 (1,3-
ding (C¼C, CX)
Fig. 4. (a) 2D structure [2-(9-((1H-imidazol-4-yl)methyl)-3-(2-amino-2-oxoethyl)-21-(2-(2-amino-4-(2-aminoacetamido)-4-oxobutanamido)-3-phenylpropanamido)-18-
(3-aminopropyl)-12-benzyl-15-(sec-butyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptaazacyclopentacosan-6-yl) acetic acid] of antibacterial compound (proposed
name: Aeritracin) obtained from thermophilic Aeribacillus pallidus SAT4 (b) The 3D crystal structure of antibacterial compound obtained from Aeribacillus pallidus SAT4 belong
to the primitive orthorhombic lattice with the cell parameters a = 12.137, b = 13.421, c = 14.097 Å.
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tatively and qualitatively based on the factors including the
microbial strains and their growth fermentation conditions
[49,3,12]. Considering the temperature and agitation rate as
critical parameters, optimum production of antibacterial com-
pound by SAT4 was observed at 55 C and 100 rpm, respectively.
During experimentation in the present study, incubation time was
evaluated from 24 to 144 h with best activity found at 48 h of
incubation and similar observation were recorded by Muaaz et al.
[35], who reported that concentration of inhibitory compound was
maximum at 48 h by B. subtilis MZ-7. pH was another important
aspect of optimization study which was “5” from the experimental
values of 4 (acidic) to 9 (basic) and Tang et al. in 1994 [46] reported
that variations in fermentation broth pH affect several cellular
developments like the regulation and controlling of the biosyn-
thesis of microbial bioactive metabolites [46,5]. Addition of carbon
and nitrogen sources in the production media optimally effect the
production of antimicrobial compounds [22]. The optimum
concentration of glutamic acid (as a source of nitrogen) andTable 4
Data processing statistics of antibacterial compound obtained by Aeribacillus pa
a STOE-IPDS II equipped with an Oxford Cryostream low-temperature unit G
Molecular formula C55
Molecular weight 1,2
Molecular composition C: 
Crystal system Tri
Space group P-1
Alp
Be
Ga
V =
Absorption coefﬁcient 0.3
No. of reﬂections collected/unique 79
No. of reﬂections used [I > 2s(I)] 60
Parameters 474
Final R indices R1
R indices (all data) R1
Structure determination SIR
Equipment STOglucose (as source of carbon) was 1.5% and 2%, respectively. In
2006, Nasser discussed that galactose and glucose intensely
improved the antibacterial activity of Corynebacterium kutscheri
and Corynebacterium xerosis, respectively [9,36,23].
In 1991, Shimogki et al. reported that the ﬁrst step in the
puriﬁcation of the antibacterial was separation of crude antibiotic
from the microbial growth followed by precipitation of proteins by
70% ammonium sulfate [43,1,26]. The absorbance of protein
fractions was observed at 280 nm [50,32] and electrophoresed
[7,4]. The band on gel appeared at the position of 37 kDa while
molecular weight of bacteriocin like substance produced by G.
toebii strain HBB-247 was recorded about 38 kDa [37].
1H and 13C NMR spectra showed the presence of alkyl groups,
amide linkage and carbonyl groups in the sample at 300 MHz. The
resonance of alkyl amines (RNH2) was observed at 3.996 ppm
while Epperson and Ming recorded that 1H NMR spectrum of the
Co(II) complex of bacitracin mixture with amino acids appeared at
1–12 ppm and found the positions of the protons in the amino acid
(a, b, etc.) at 11.7 ppm [16]. The resonance at 69.69 ppm showedllidus SAT4 was identiﬁed and calculated from a single crystal source using
ermany.
H82 N16 O17
39.37
0.533, H: 0.067, N: 0.181, O: 0.219
clinic
; Shoenﬂies: C1-1, a = 12.137, b = 13.421, c = 14.097
ha = 84.269 (5) Å
ta = 81.71 (5) Å
mma = 80.86 (5) Å
 2116.8 (2) Å3
4 mm–1
55
45
 = 0.0282, wR2 = 0.0677
 = 0.0394, wR2 = 0.0750
97, SHELXL97 and WinGX
E-IPDS II equipped with an Oxford Cryostream low-temperature unit
Table 5
Thermostability analysis of cell free supernatant and pure antibacterial compound at various temperatures against Micrococcus luteus and Staphylococcus aureus as indicator
bacterial strains.
Sample Zone of inhibitiona
(mm) (before
treatment at 37 C)
(A0)
Temperature (C) Activity against
M. luteus (Af) Activity against
S. aureus (Af)
M. luteus S. aureus Zone of inhibition (mm) % age loss of activityb Zone of inhibition (mm) % age loss of activity*
Cell free supernatant 22 25 45 14 36 12 52
50 18 18 15 40
55 22 0.00 18 28
60 10 55 8 68
45 18 18 20 20
Analysis after puriﬁcation 50 15 31 16 36
55 12 45 12 52
60 8 63 10 60
a Formula: A0 Af/A0 100, where A0: activity control; Af: activity after treatment.
b 0.1% concentration of puriﬁed antibacterial compound produced by Aeribacillus pallidus SAT4 was used before treatment.
S.A. Muhammad, S. Ahmed / Biotechnology Reports 8 (2015) 72–80 79the effects of electronegative atom (CO) while 13C spectrum
reported by Kim et al. showed carbon signal of C¼O at 218.04 (C-3)
and C¼C at 150.96 (C-20), 109.47 (C-29) [28].
In 2001, Kim et al. reported that the structure of antibacterial
compound was found to be orthorhombic which consisted of 3-
different sides and three of 90 angle. The bond length of 1.2223
and 1.3639 Å exhibited the presence of C¼O (C3-O1) and C¼C
(C20-C29), respectively [28].
The thermostability of both cell free supernatant and puriﬁed
antibacterial compound showed that cell free supernatant was
relatively stable at 55 C showing 0 and 28% loss of activity against
M. luteus and S. aureus, respectively. The activity of pure
antibacterial compound was decreased 45% against Micrococcus
lutes and 52% against S. aureus after treatment at 55 C [13].
In conclusion, novel peptide antibacterial compound (proposed
name: Aeritracin) produced by a thermophilic A. pallidus SAT4 is
effective against S. aureus, M. luteus, and P. aeruginosa. This
antibiotic would be a new addition in pharmaceutical research and
drug development.
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